GSA Capital Partners LLP Reduces Stock Position in Procter & Gamble Company (The) $PG

GSA Capital Partners LLP trimmed its stake in shares of Procter & Gamble Company (The) (NYSE:PG) by 86.8% in the 3rd quarter, Holdings Channel reports. The firm owned 2,742 shares of the company’s stock after selling 17,977 shares during the period. GSA Capital Partners LLP’s holdings in Procter & Gamble were worth $421,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Halbert Hargrove Global Advisors LLC bought a new position in shares of Procter & Gamble during the 3rd quarter valued at $25,000. Corundum Trust Company INC bought a new position in Procter & Gamble in the third quarter valued at about $32,000. Marquette Asset Management LLC bought a new position in Procter & Gamble in the third quarter valued at about $37,000. Manning & Napier Advisors LLC purchased a new position in Procter & Gamble in the third quarter worth about $44,000. Finally, Collier Financial bought a new stake in shares of Procter & Gamble during the 3rd quarter valued at about $47,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Procter & Gamble Trading Down 1.1%

Shares of Procter & Gamble stock opened at $163.45 on Thursday. Procter & Gamble Company has a fifty-two week low of $137.62 and a fifty-two week high of $179.99. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.51 and a current ratio of 0.72. The company has a market capitalization of $379.85 billion, a P/E ratio of 24.21, a P/E/G ratio of 5.52 and a beta of 0.38. The company has a fifty day moving average of $150.14 and a 200 day moving average of $150.94.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings data on Thursday, January 22nd. The company reported $1.88 EPS for the quarter, beating the consensus estimate of $1.86 by $0.02. The business had revenue of $22.21 billion for the quarter, compared to the consensus estimate of $22.36 billion. Procter & Gamble had a return on equity of 32.21% and a net margin of 19.30%.The business’s revenue was up 1.5% on a year-over-year basis. During the same period in the previous year, the business earned $1.88 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, sell-side analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, February 17th. Shareholders of record on Friday, January 23rd were paid a $1.0568 dividend. This represents a $4.23 annualized dividend and a yield of 2.6%. The ex-dividend date was Friday, January 23rd. Procter & Gamble’s dividend payout ratio is presently 62.67%.

Analyst Ratings Changes

Several brokerages have recently weighed in on PG. Piper Sandler began coverage on shares of Procter & Gamble in a research note on Wednesday, January 7th. They issued a “neutral” rating and a $150.00 price objective on the stock. Jefferies Financial Group upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating and lifted their price target for the stock from $156.00 to $179.00 in a research note on Tuesday, December 16th. TD Cowen lowered Procter & Gamble from a “buy” rating to a “hold” rating and upped their price objective for the stock from $150.00 to $156.00 in a research note on Tuesday, January 27th. JPMorgan Chase & Co. upgraded Procter & Gamble from a “neutral” rating to an “overweight” rating and lifted their target price for the company from $157.00 to $165.00 in a research report on Friday, January 23rd. Finally, UBS Group upped their price target on Procter & Gamble from $161.00 to $170.00 and gave the stock a “buy” rating in a research report on Friday, January 23rd. Fourteen equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $168.33.

Insider Buying and Selling at Procter & Gamble

In related news, insider Susan Street Whaley sold 1,809 shares of the firm’s stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $159.46, for a total transaction of $288,463.14. Following the completion of the transaction, the insider directly owned 30,215 shares of the company’s stock, valued at approximately $4,818,083.90. This trade represents a 5.65% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Moses Victor Javier Aguilar sold 15,169 shares of the business’s stock in a transaction on Friday, February 13th. The stock was sold at an average price of $162.28, for a total transaction of $2,461,625.32. Following the completion of the sale, the insider owned 44,735 shares in the company, valued at approximately $7,259,595.80. The trade was a 25.32% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 343,069 shares of company stock worth $54,545,448. Insiders own 0.20% of the company’s stock.

Procter & Gamble News Roundup

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: New product launches and sustainability push (Tide evo concentrated, waterless detergent tile; Head & Shoulders BARE scalp serum) support premiumization, ESG positioning and potentially higher margins — a structural driver of investor enthusiasm. P&G Sustainability Push And New Formats Underpin Valuation Case
• Positive Sentiment: Recent results: P&G topped fiscal Q2 EPS estimates and reiterated FY‑26 guidance (6.83–7.09 EPS), which has prompted analyst upgrades and helped fuel a short‑term rally. Assessing Procter & Gamble (PG) Valuation After Earnings Beat And Tide Evo Launch
• Positive Sentiment: Portfolio rationalization efforts aim to streamline SKUs and focus investment on higher‑growth categories — a strategic move that can boost agility and margin expansion over time. Is Portfolio Rationalization the Key to Procter & Gamble’s Agility?
• Neutral Sentiment: Analyst and peer comparisons are mixed: some firms raise targets and reaffirm buys while others remain neutral, reflecting differing views on growth vs valuation. MarketBeat coverage and analyst notes
• Neutral Sentiment: Market action: P&G has been a visible driver in futures/market moves at times, but that can amplify intraday swings unrelated to fundamentals. Procter & Gamble Leads the Way In S&P 500 Futures Trends
• Negative Sentiment: Insider selling disclosed: Director/executive sell of ~1,809 shares (~$288k) was filed — a small but visible signal that can add to intraday selling pressure. Procter & Gamble Insider Sells $288,463.14 in Stock
• Negative Sentiment: Valuation and relative underperformance: P&G has lagged the staples group over the last year and some analysts warn of limited near‑term upside versus peers, which can prompt profit‑taking after the recent 30‑day strength. How Is Procter & Gamble’s Stock Performance Compared to Other Consumer Staples Stocks?
• Negative Sentiment: Analyst caution piece highlights one reason to stay skeptical (valuation/competition), reinforcing mixed sentiment that can weigh on the name intraday. 2 Reasons to Like PG and 1 to Stay Skeptical

Procter & Gamble Company Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.